Medical monitoring

Study Finds Remote Cardiac Monitoring Programs Significantly More Successful When Patients—Not Devices—Are Primary Focus

Retrieved on: 
Wednesday, May 12, 2021
Data management, Medical devices, Health, Technology, Practice Management, Cardiology, Cardiac electrophysiology, Medical monitoring, Cardiac monitoring

b'Vector Remote Care today announced the results of a survey on the adoption of remote cardiac monitoring solutions and their impact on managing heart disease in the U.S.

Key Points: 
  • b'Vector Remote Care today announced the results of a survey on the adoption of remote cardiac monitoring solutions and their impact on managing heart disease in the U.S.
  • The findings reveal that remote cardiac monitoring (RCM) programs that focus on just remote device data management are missing out on both clinical and financial benefits.
  • The 110 respondents included electrophysiologists, cardiologists, cardiac device technicians, cardiac practice managers, LPNs, RNs, allied medical professionals, cardiac medical assistants, and cardiac service line managers.\nFounded in 2017, Vector is a complete cardiac digital health solution that makes it simple for care teams to accurately capture, manage, analyze, and act on remote cardiac data.
  • We help monitor and manage the entire cardiac remote monitoring lifecycle \xe2\x80\x93 from patient set up and data transmission to analysis and billing \xe2\x80\x93 so teams stay focused on what matters most: delivering the best care.

Assure Holdings Sets First Quarter 2021 Conference Call for Friday, May 14, 2021, at 12:00 p.m. ET

Retrieved on: 
Tuesday, May 11, 2021
Clinical medicine, Anesthesia, Electrodiagnosis, Electroencephalography, Intraoperative neurophysiological monitoring, Medical monitoring, XE-class submarine, Branches of biology

The Company will report its financial results in a press release prior to the conference call.\nPlease call the conference telephone number 5-10 minutes prior to the start time.

Key Points: 
  • The Company will report its financial results in a press release prior to the conference call.\nPlease call the conference telephone number 5-10 minutes prior to the start time.
  • Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided.
  • Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commission\xe2\x80\x99s Gold Seal of Approval\xc2\xae.
  • For more information, visit the Company\xe2\x80\x99s website at www.assureneuromonitoring.com .\nThis news release may contain \xe2\x80\x9cforward-looking statements\xe2\x80\x9d within the meaning of applicable securities laws.

Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market

Retrieved on: 
Tuesday, May 11, 2021
Articles, Health informatics, Technology, Science and technology, Telehealth, Assistive technology, Telemedicine, Medical monitoring, Remote patient monitoring, eHealth, Electronic health record

Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before.

Key Points: 
  • Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before.
  • As a result of COVID-19, the global market for patient monitoring and telehealth increased by more than $2.8 billion in 2020 to reach $54.5 billion, according to leading medical market research publisher Kalorama Information in the new report Remote Patient Monitoring .
  • The demand to integrate data processing capabilities and electronic medical record (EMR) transfer options has also fueled the market.
  • Further, there is an increasing trend to upgrade to ambulatory and hand-held devices.\nLooking ahead, Kalorama Information forecasts the global patient monitoring and telehealth market will experience healthy growth between 2021 and 2025.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services

Retrieved on: 
Tuesday, May 11, 2021
Medicine, Medical specialties, Clinical medicine, Medical monitoring, Pulse oximetry, Blood glucose monitoring, Monitoring

NuGenHealth will also supply WM&C with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.

Key Points: 
  • NuGenHealth will also supply WM&C with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.
  • Remote patient monitoring is a service that was positioned for significant growth as the pandemic has accelerated the practice of remote patient monitoring to improve outcomes.
  • We have selected NuGenHealth because the software is easy to install and maintain, has a user-friendly interface, and provides efficiencies in patient management.
  • Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.\n'

VeeMed and BioIntelliSense Partner to Advance Remote Patient Monitoring Care with Continuous Vital Sign Data and Clinical Analytics

Retrieved on: 
Tuesday, May 11, 2021
Articles, Health informatics, Health, Technology, Telehealth, Telemedicine, Medical monitoring, Remote patient monitoring, Monitoring, eHealth

By giving patients an effortless wearable experience to seamlessly capture continuous vital sign data via our telehealth platform, healthcare systems can deliver the absolute, most advanced RPM care," said Dr. Arshad Ali, chief medical officer and president, VeeMed.

Key Points: 
  • By giving patients an effortless wearable experience to seamlessly capture continuous vital sign data via our telehealth platform, healthcare systems can deliver the absolute, most advanced RPM care," said Dr. Arshad Ali, chief medical officer and president, VeeMed.
  • The FDA-cleared BioSticker and medical-grade BioButton devices qualify for reimbursement under the technology code of 99454.\nBioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
  • Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience.
  • Through the platform\'s advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care at home.

Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes

Retrieved on: 
Monday, May 10, 2021
Technology, Pharmaceutical, Venture capital, Teens, Medical devices, Hospitals, Fitness & Nutrition, Finance, Biotechnology, Professional services, Health, Women, Seniors, Practice Management, Managed care, MEN, Consumer, Medical Supplies, Software, FDA, Diabetes, Hardware, Data management, Clinical medicine, Medicine, Branches of biology, Medical monitoring, Bigfoot Biomedical, Diabetes, Peptide hormones, Recombinant proteins, Insulin, Diabetes management, Bigfoot, Bigfoot Biomedical, Inc., Bigfoot Biomedical CEO Jeffrey Brewer, BIGFOOT BIOMEDICAL, INC., BIGFOOT BIOMEDICAL CEO JEFFREY BREWER

The Bigfoot Unity smart pen caps provide on-demand, insulin dose decision support to minimize guesswork and enable patients to follow their doctor\xe2\x80\x99s instructions in a convenient, simple way.

Key Points: 
  • The Bigfoot Unity smart pen caps provide on-demand, insulin dose decision support to minimize guesswork and enable patients to follow their doctor\xe2\x80\x99s instructions in a convenient, simple way.
  • The Bigfoot Unity System features first-of-its-kind smart pen caps that display insulin dose recommendations on demand, so users can follow their doctor\xe2\x80\x99s instructions in a convenient, simple way.
  • "Through Abbott\'s collaboration with Bigfoot Biomedical, we\'re integrating our revolutionary, easy-to-use FreeStyle Libre 2 technology with the Bigfoot Unity System to provide automated information for personalized diabetes management.
  • The smart pen cap also directly displays the health care provider\xe2\x80\x99s suggested meal insulin doses with the correction dose.

NONIN MEDICAL’S CO-PILOT RECOGNIZED IN FAST COMPANY’S 2021 WORLD CHANGING IDEAS AWARDS

Retrieved on: 
Monday, May 10, 2021
Medical specialties, Medicine, Clinical medicine, Hemoglobins, Cardiology, Medical monitoring, Pulse oximetry, Respiratory physiology, Methemoglobin, Monitoring, Carboxyhemoglobin

b'MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- Nonin Medical, a global leader in noninvasive medical monitoring and the manufacturer of the CO-Pilot\xe2\x84\xa2 Wireless Handheld Multi-Parameter System, received an honorable mention in Fast Company\xe2\x80\x99s 5th annual World Changing Ideas Awards in the health category.

Key Points: 
  • b'MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- Nonin Medical, a global leader in noninvasive medical monitoring and the manufacturer of the CO-Pilot\xe2\x84\xa2 Wireless Handheld Multi-Parameter System, received an honorable mention in Fast Company\xe2\x80\x99s 5th annual World Changing Ideas Awards in the health category.
  • It offers reliable readings to allow for improved first responder patient care or any emergency setting outside of the hospital.
  • The CO-Pilot simultaneously tracks patient pulse oximetry (SpO2), pulse rate, carboxyhemoglobin (COHb) and methemoglobin (MetHb); cerebral and tissue oximetry (rSO2) can be measured using an additional sensor.\nThe World Changing Ideas Awards recognize innovators in categories such as Health & Wellness and AI & Data.
  • To learn more, visit nonin.com .\nABOUT THE WORLD CHANGING IDEAS AWARDS:\nWorld Changing Ideas is one of Fast Company\xe2\x80\x99s major annual awards programs and is focused on social good, seeking to elevate finished products and brave concepts that make the world better.

Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality

Retrieved on: 
Monday, May 10, 2021
General Health, Medical devices, Hospitals, Health, Pharmaceutical, Medical specialties, Medicine, Clinical medicine, Intensive care medicine, Medical emergencies, Anesthesia, Cardiology, Medical monitoring, Pulse oximetry, Monitoring, Septic shock, Lactic

The researchers found that O3 trends correlated significantly with a variety of other hemodynamic variables and lactic acid levels commonly used in the monitoring of septic shock patients.

Key Points: 
  • The researchers found that O3 trends correlated significantly with a variety of other hemodynamic variables and lactic acid levels commonly used in the monitoring of septic shock patients.
  • The most important observation from this study is the significant correlation between NIRS oximetry readings and hemodynamic variables, especially lactic acid [and] central venous oxygen saturation in patients experiencing shock.
  • Our mission is to improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications.
  • Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity.

ClearDATA and BioIntelliSense Combine Capabilities to Enhance Remote Patient Monitoring Platform Security and Compliance

Retrieved on: 
Thursday, May 6, 2021
Data management, Health, Security, Medical devices, Technology, Managed care, Software, Health informatics, Telehealth, Medical monitoring, As a service, Data as a service, Daas, Health, Remote patient monitoring, HITRUST, Medical record, Articles, BioIntelliSense, ClearDATA, BIOINTELLISENSE, CLEARDATA

The BioIntelliSense Data-as-a-Service (DaaS) platform remotely captures, stores and transmits encrypted patient data for advanced analytics in the BioCloud supported by ClearDATA safeguards for managing sensitive patient data (PHI/PII) with its HITRUST-certified SaaS platform and services backed by deep expertise in healthcare security and the cloud.

Key Points: 
  • The BioIntelliSense Data-as-a-Service (DaaS) platform remotely captures, stores and transmits encrypted patient data for advanced analytics in the BioCloud supported by ClearDATA safeguards for managing sensitive patient data (PHI/PII) with its HITRUST-certified SaaS platform and services backed by deep expertise in healthcare security and the cloud.
  • For more information on how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services, visit BioIntelliSense.com .\nBioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
  • Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures minute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience.
  • For more information, visit ClearDATA at www.cleardata.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210506005817/en/\n"

Vivify Health Recognized for Remote Patient Care Innovation in 2021 MedTech Breakthrough Awards Program

Retrieved on: 
Thursday, May 6, 2021
Telehealth, Medical monitoring, Remote patient monitoring

"We are grateful to receive this industry recognition from MedTech Breakthrough for our perseverance in continuing to deliver what our customers need for scaling their remote care.

Key Points: 
  • "We are grateful to receive this industry recognition from MedTech Breakthrough for our perseverance in continuing to deliver what our customers need for scaling their remote care.
  • "Congratulations to the entire team at Vivify Health for stepping up and innovating in a time when it\'s needed the most.
  • In a field that has recently exploded, Vivify Health is our choice for \'Best Remote Patient Monitoring Solution\' for 2021.
  • "\nVivify Health\'s platform for Remote Patient Monitoring (RPM) empowers care where it is needed the most, while delivering advanced program management to set providers apart.